nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—glaucoma	0.606	1	CbGaD
Aminosalicylic Acid—Dermatitis exfoliative—Dorzolamide—glaucoma	0.00169	0.00716	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Carteolol—glaucoma	0.00164	0.00694	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Dorzolamide—glaucoma	0.00164	0.00693	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Pilocarpine—glaucoma	0.0016	0.00677	CcSEcCtD
Aminosalicylic Acid—Flatulence—Carbachol—glaucoma	0.00158	0.0067	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Pilocarpine—glaucoma	0.00155	0.00655	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methazolamide—glaucoma	0.00148	0.00628	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Diclofenamide—glaucoma	0.00147	0.00624	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methazolamide—glaucoma	0.00136	0.00574	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Diclofenamide—glaucoma	0.00132	0.00557	CcSEcCtD
Aminosalicylic Acid—Anorexia—Diclofenamide—glaucoma	0.00128	0.00542	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Acetazolamide—glaucoma	0.00125	0.0053	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Dorzolamide—glaucoma	0.00125	0.00529	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00124	0.00525	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methazolamide—glaucoma	0.00118	0.00499	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Latanoprost—glaucoma	0.00117	0.00497	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Betaxolol—glaucoma	0.00117	0.00496	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Diclofenamide—glaucoma	0.00117	0.00494	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Latanoprost—glaucoma	0.00116	0.00492	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00116	0.00491	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Apraclonidine—glaucoma	0.00115	0.00486	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Dorzolamide—glaucoma	0.00115	0.00486	CcSEcCtD
Aminosalicylic Acid—Purpura—Betaxolol—glaucoma	0.00109	0.00461	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Metipranolol—glaucoma	0.00109	0.0046	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Travoprost—glaucoma	0.00109	0.0046	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Travoprost—glaucoma	0.00108	0.00457	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methazolamide—glaucoma	0.00108	0.00455	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Betaxolol—glaucoma	0.00108	0.00455	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Brinzolamide—glaucoma	0.00107	0.00454	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methazolamide—glaucoma	0.00107	0.00452	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Brinzolamide—glaucoma	0.00106	0.00451	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Diclofenamide—glaucoma	0.00106	0.0045	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Pilocarpine—glaucoma	0.00104	0.00442	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carbachol—glaucoma	0.00104	0.00439	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Carbachol—glaucoma	0.00104	0.00439	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Acetazolamide—glaucoma	0.00103	0.00435	CcSEcCtD
Aminosalicylic Acid—Urticaria—Levobunolol—glaucoma	0.00103	0.00434	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Carteolol—glaucoma	0.00101	0.00426	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000992	0.0042	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Brimonidine—glaucoma	0.000986	0.00417	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methazolamide—glaucoma	0.000983	0.00416	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methazolamide—glaucoma	0.000978	0.00414	CcSEcCtD
Aminosalicylic Acid—Dizziness—Metipranolol—glaucoma	0.000976	0.00413	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000962	0.00407	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Levobunolol—glaucoma	0.000952	0.00403	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Brinzolamide—glaucoma	0.000946	0.004	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Dorzolamide—glaucoma	0.000942	0.00399	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Acetazolamide—glaucoma	0.000939	0.00398	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Apraclonidine—glaucoma	0.000939	0.00397	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Travoprost—glaucoma	0.000938	0.00397	CcSEcCtD
Aminosalicylic Acid—Flatulence—Brinzolamide—glaucoma	0.000932	0.00394	CcSEcCtD
Aminosalicylic Acid—Rash—Metipranolol—glaucoma	0.00093	0.00394	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Apraclonidine—glaucoma	0.00093	0.00394	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Metipranolol—glaucoma	0.000929	0.00393	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Brinzolamide—glaucoma	0.000926	0.00392	CcSEcCtD
Aminosalicylic Acid—Headache—Metipranolol—glaucoma	0.000924	0.00391	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Bimatoprost—glaucoma	0.00091	0.00385	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Timolol—glaucoma	0.000908	0.00385	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carteolol—glaucoma	0.000904	0.00383	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Bimatoprost—glaucoma	0.000902	0.00382	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Carbachol—glaucoma	0.000897	0.0038	CcSEcCtD
Aminosalicylic Acid—Flatulence—Pilocarpine—glaucoma	0.000896	0.00379	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Pilocarpine—glaucoma	0.00089	0.00377	CcSEcCtD
Aminosalicylic Acid—Dizziness—Diclofenamide—glaucoma	0.000889	0.00376	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Levobunolol—glaucoma	0.000884	0.00374	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Timolol—glaucoma	0.000878	0.00372	CcSEcCtD
Aminosalicylic Acid—Nausea—Metipranolol—glaucoma	0.000876	0.00371	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carbachol—glaucoma	0.000867	0.00367	CcSEcCtD
Aminosalicylic Acid—Headache—Carteolol—glaucoma	0.000856	0.00362	CcSEcCtD
Aminosalicylic Acid—Vomiting—Diclofenamide—glaucoma	0.000854	0.00362	CcSEcCtD
Aminosalicylic Acid—Dizziness—Levobunolol—glaucoma	0.000854	0.00362	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000852	0.0036	CcSEcCtD
Aminosalicylic Acid—Rash—Diclofenamide—glaucoma	0.000847	0.00359	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methazolamide—glaucoma	0.000847	0.00358	CcSEcCtD
Aminosalicylic Acid—Headache—Diclofenamide—glaucoma	0.000842	0.00356	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Acetazolamide—glaucoma	0.000839	0.00355	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carbachol—glaucoma	0.000834	0.00353	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Clonidine—glaucoma	0.000834	0.00353	CcSEcCtD
Aminosalicylic Acid—Rash—Carbachol—glaucoma	0.000827	0.0035	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000827	0.0035	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carbachol—glaucoma	0.000826	0.0035	CcSEcCtD
Aminosalicylic Acid—Headache—Carbachol—glaucoma	0.000822	0.00348	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betaxolol—glaucoma	0.00082	0.00347	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—glaucoma	0.000815	0.427	CrCbGaD
Aminosalicylic Acid—Leukopenia—Pilocarpine—glaucoma	0.000814	0.00344	CcSEcCtD
Aminosalicylic Acid—Nausea—Carteolol—glaucoma	0.000812	0.00344	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00081	0.00343	CcSEcCtD
Aminosalicylic Acid—Headache—Levobunolol—glaucoma	0.000809	0.00342	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Brimonidine—glaucoma	0.000806	0.00341	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000801	0.00339	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.0008	0.00338	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Brimonidine—glaucoma	0.000798	0.00338	CcSEcCtD
Aminosalicylic Acid—Nausea—Diclofenamide—glaucoma	0.000798	0.00338	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betaxolol—glaucoma	0.000793	0.00336	CcSEcCtD
Aminosalicylic Acid—Dizziness—Latanoprost—glaucoma	0.000792	0.00335	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methazolamide—glaucoma	0.000787	0.00333	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Apraclonidine—glaucoma	0.000783	0.00331	CcSEcCtD
Aminosalicylic Acid—Rash—Methazolamide—glaucoma	0.00078	0.0033	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methazolamide—glaucoma	0.000779	0.0033	CcSEcCtD
Aminosalicylic Acid—Nausea—Carbachol—glaucoma	0.000779	0.0033	CcSEcCtD
Aminosalicylic Acid—Headache—Methazolamide—glaucoma	0.000775	0.00328	CcSEcCtD
Aminosalicylic Acid—Nausea—Levobunolol—glaucoma	0.000767	0.00325	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Travoprost—glaucoma	0.000767	0.00324	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Travoprost—glaucoma	0.000759	0.00321	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Apraclonidine—glaucoma	0.000757	0.0032	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Brinzolamide—glaucoma	0.000757	0.0032	CcSEcCtD
Aminosalicylic Acid—Rash—Latanoprost—glaucoma	0.000755	0.0032	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Betaxolol—glaucoma	0.000755	0.00319	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Latanoprost—glaucoma	0.000754	0.00319	CcSEcCtD
Aminosalicylic Acid—Headache—Latanoprost—glaucoma	0.00075	0.00318	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Brinzolamide—glaucoma	0.00075	0.00317	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dorzolamide—glaucoma	0.000748	0.00317	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Acetazolamide—glaucoma	0.000745	0.00315	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000739	0.00313	CcSEcCtD
Aminosalicylic Acid—Nausea—Methazolamide—glaucoma	0.000735	0.00311	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Pilocarpine—glaucoma	0.000726	0.00307	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Brimonidine—glaucoma	0.00071	0.003	CcSEcCtD
Aminosalicylic Acid—Anorexia—Pilocarpine—glaucoma	0.000707	0.00299	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Apraclonidine—glaucoma	0.000705	0.00299	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dorzolamide—glaucoma	0.000682	0.00289	CcSEcCtD
Aminosalicylic Acid—Urticaria—Acetazolamide—glaucoma	0.00068	0.00288	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Acetazolamide—glaucoma	0.000677	0.00287	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Travoprost—glaucoma	0.000675	0.00286	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Brinzolamide—glaucoma	0.000671	0.00284	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Timolol—glaucoma	0.00067	0.00284	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000666	0.00282	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Apraclonidine—glaucoma	0.000655	0.00277	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Pilocarpine—glaucoma	0.000645	0.00273	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dorzolamide—glaucoma	0.000642	0.00272	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00064	0.00271	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—glaucoma	0.00064	0.335	CrCbGaD
Aminosalicylic Acid—Gastrointestinal pain—Travoprost—glaucoma	0.000639	0.00271	CcSEcCtD
Aminosalicylic Acid—Dizziness—Apraclonidine—glaucoma	0.000633	0.00268	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Betaxolol—glaucoma	0.000632	0.00267	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dorzolamide—glaucoma	0.000624	0.00264	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dorzolamide—glaucoma	0.000621	0.00263	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dorzolamide—glaucoma	0.000621	0.00263	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Betaxolol—glaucoma	0.000619	0.00262	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Travoprost—glaucoma	0.000618	0.00262	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Timolol—glaucoma	0.000616	0.00261	CcSEcCtD
Aminosalicylic Acid—Dizziness—Bimatoprost—glaucoma	0.000614	0.0026	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000614	0.0026	CcSEcCtD
Aminosalicylic Acid—Urticaria—Brinzolamide—glaucoma	0.000613	0.0026	CcSEcCtD
Aminosalicylic Acid—Vomiting—Apraclonidine—glaucoma	0.000609	0.00258	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Pilocarpine—glaucoma	0.000607	0.00257	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Brimonidine—glaucoma	0.000606	0.00256	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Apraclonidine—glaucoma	0.000603	0.00255	CcSEcCtD
Aminosalicylic Acid—Headache—Apraclonidine—glaucoma	0.0006	0.00254	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Pilocarpine—glaucoma	0.000586	0.00248	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Pilocarpine—glaucoma	0.000586	0.00248	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Acetazolamide—glaucoma	0.000586	0.00248	CcSEcCtD
Aminosalicylic Acid—Rash—Bimatoprost—glaucoma	0.000585	0.00248	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Bimatoprost—glaucoma	0.000585	0.00248	CcSEcCtD
Aminosalicylic Acid—Anaemia—Betaxolol—glaucoma	0.000584	0.00247	CcSEcCtD
Aminosalicylic Acid—Headache—Bimatoprost—glaucoma	0.000582	0.00246	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Clonidine—glaucoma	0.000581	0.00246	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Clonidine—glaucoma	0.00058	0.00246	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dorzolamide—glaucoma	0.000578	0.00245	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Travoprost—glaucoma	0.000576	0.00244	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Clonidine—glaucoma	0.000575	0.00244	CcSEcCtD
Aminosalicylic Acid—Nausea—Apraclonidine—glaucoma	0.000569	0.00241	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Brinzolamide—glaucoma	0.000569	0.00241	CcSEcCtD
Aminosalicylic Acid—Dizziness—Acetazolamide—glaucoma	0.000566	0.0024	CcSEcCtD
Aminosalicylic Acid—Anorexia—Clonidine—glaucoma	0.000565	0.00239	CcSEcCtD
Aminosalicylic Acid—Nausea—Bimatoprost—glaucoma	0.000551	0.00233	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Pilocarpine—glaucoma	0.000547	0.00231	CcSEcCtD
Aminosalicylic Acid—Vomiting—Acetazolamide—glaucoma	0.000545	0.0023	CcSEcCtD
Aminosalicylic Acid—Dizziness—Brimonidine—glaucoma	0.000544	0.0023	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dorzolamide—glaucoma	0.000537	0.00227	CcSEcCtD
Aminosalicylic Acid—Headache—Acetazolamide—glaucoma	0.000537	0.00227	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Travoprost—glaucoma	0.000535	0.00226	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000534	0.00226	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Brinzolamide—glaucoma	0.000528	0.00224	CcSEcCtD
Aminosalicylic Acid—Dizziness—Dorzolamide—glaucoma	0.000519	0.0022	CcSEcCtD
Aminosalicylic Acid—Rash—Brimonidine—glaucoma	0.000518	0.00219	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Brimonidine—glaucoma	0.000518	0.00219	CcSEcCtD
Aminosalicylic Acid—Dizziness—Travoprost—glaucoma	0.000517	0.00219	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Timolol—glaucoma	0.000516	0.00219	CcSEcCtD
Aminosalicylic Acid—Headache—Brimonidine—glaucoma	0.000515	0.00218	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Clonidine—glaucoma	0.000515	0.00218	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Clonidine—glaucoma	0.000511	0.00216	CcSEcCtD
Aminosalicylic Acid—Dizziness—Brinzolamide—glaucoma	0.00051	0.00216	CcSEcCtD
Aminosalicylic Acid—Nausea—Acetazolamide—glaucoma	0.000509	0.00215	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Pilocarpine—glaucoma	0.000508	0.00215	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betaxolol—glaucoma	0.000506	0.00214	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Timolol—glaucoma	0.000506	0.00214	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betaxolol—glaucoma	0.000505	0.00214	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Betaxolol—glaucoma	0.000501	0.00212	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dorzolamide—glaucoma	0.000499	0.00211	CcSEcCtD
Aminosalicylic Acid—Rash—Dorzolamide—glaucoma	0.000495	0.0021	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dorzolamide—glaucoma	0.000495	0.00209	CcSEcCtD
Aminosalicylic Acid—Rash—Travoprost—glaucoma	0.000493	0.00209	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Travoprost—glaucoma	0.000492	0.00208	CcSEcCtD
Aminosalicylic Acid—Headache—Dorzolamide—glaucoma	0.000492	0.00208	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betaxolol—glaucoma	0.000492	0.00208	CcSEcCtD
Aminosalicylic Acid—Vomiting—Brinzolamide—glaucoma	0.000491	0.00208	CcSEcCtD
Aminosalicylic Acid—Dizziness—Pilocarpine—glaucoma	0.000491	0.00208	CcSEcCtD
Aminosalicylic Acid—Headache—Travoprost—glaucoma	0.00049	0.00207	CcSEcCtD
Aminosalicylic Acid—Nausea—Brimonidine—glaucoma	0.000488	0.00207	CcSEcCtD
Aminosalicylic Acid—Rash—Brinzolamide—glaucoma	0.000487	0.00206	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Brinzolamide—glaucoma	0.000486	0.00206	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Clonidine—glaucoma	0.000484	0.00205	CcSEcCtD
Aminosalicylic Acid—Headache—Brinzolamide—glaucoma	0.000483	0.00205	CcSEcCtD
Aminosalicylic Acid—Vomiting—Pilocarpine—glaucoma	0.000472	0.002	CcSEcCtD
Aminosalicylic Acid—Urticaria—Clonidine—glaucoma	0.000471	0.00199	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Clonidine—glaucoma	0.000468	0.00198	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Clonidine—glaucoma	0.000468	0.00198	CcSEcCtD
Aminosalicylic Acid—Rash—Pilocarpine—glaucoma	0.000468	0.00198	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Pilocarpine—glaucoma	0.000467	0.00198	CcSEcCtD
Aminosalicylic Acid—Nausea—Dorzolamide—glaucoma	0.000466	0.00197	CcSEcCtD
Aminosalicylic Acid—Headache—Pilocarpine—glaucoma	0.000465	0.00197	CcSEcCtD
Aminosalicylic Acid—Nausea—Travoprost—glaucoma	0.000464	0.00197	CcSEcCtD
Aminosalicylic Acid—Nausea—Brinzolamide—glaucoma	0.000458	0.00194	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—glaucoma	0.000453	0.238	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Betaxolol—glaucoma	0.000448	0.0019	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betaxolol—glaucoma	0.000445	0.00188	CcSEcCtD
Aminosalicylic Acid—Nausea—Pilocarpine—glaucoma	0.000441	0.00187	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000436	0.00185	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Clonidine—glaucoma	0.000436	0.00185	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Timolol—glaucoma	0.000413	0.00175	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betaxolol—glaucoma	0.00041	0.00173	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Timolol—glaucoma	0.000409	0.00173	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betaxolol—glaucoma	0.000408	0.00173	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Clonidine—glaucoma	0.000405	0.00172	CcSEcCtD
Aminosalicylic Acid—Anorexia—Timolol—glaucoma	0.000402	0.0017	CcSEcCtD
Aminosalicylic Acid—Dizziness—Clonidine—glaucoma	0.000392	0.00166	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Betaxolol—glaucoma	0.00038	0.00161	CcSEcCtD
Aminosalicylic Acid—Vomiting—Clonidine—glaucoma	0.000377	0.00159	CcSEcCtD
Aminosalicylic Acid—Rash—Clonidine—glaucoma	0.000374	0.00158	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Clonidine—glaucoma	0.000373	0.00158	CcSEcCtD
Aminosalicylic Acid—Headache—Clonidine—glaucoma	0.000371	0.00157	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Timolol—glaucoma	0.000366	0.00155	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Timolol—glaucoma	0.000364	0.00154	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betaxolol—glaucoma	0.000353	0.00149	CcSEcCtD
Aminosalicylic Acid—Nausea—Clonidine—glaucoma	0.000352	0.00149	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Timolol—glaucoma	0.000345	0.00146	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betaxolol—glaucoma	0.000341	0.00144	CcSEcCtD
Aminosalicylic Acid—Urticaria—Timolol—glaucoma	0.000335	0.00142	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Timolol—glaucoma	0.000333	0.00141	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Timolol—glaucoma	0.000333	0.00141	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betaxolol—glaucoma	0.000328	0.00139	CcSEcCtD
Aminosalicylic Acid—Rash—Betaxolol—glaucoma	0.000325	0.00138	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betaxolol—glaucoma	0.000325	0.00138	CcSEcCtD
Aminosalicylic Acid—Headache—Betaxolol—glaucoma	0.000323	0.00137	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Timolol—glaucoma	0.00031	0.00131	CcSEcCtD
Aminosalicylic Acid—Nausea—Betaxolol—glaucoma	0.000306	0.0013	CcSEcCtD
Aminosalicylic Acid—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000295	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—BAD—glaucoma	0.000293	0.00188	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Timolol—glaucoma	0.000288	0.00122	CcSEcCtD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—BAD—glaucoma	0.000286	0.00183	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000284	0.00182	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000284	0.00182	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000284	0.00182	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—TNF—glaucoma	0.000282	0.0018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CTSA—glaucoma	0.000279	0.00179	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Timolol—glaucoma	0.000279	0.00118	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNF—glaucoma	0.000275	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—NGF—glaucoma	0.00027	0.00173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—CDKN2A—glaucoma	0.000269	0.00172	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Timolol—glaucoma	0.000268	0.00113	CcSEcCtD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—MMP9—glaucoma	0.000268	0.00172	CbGpPWpGaD
Aminosalicylic Acid—Rash—Timolol—glaucoma	0.000266	0.00112	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Timolol—glaucoma	0.000265	0.00112	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000265	0.0017	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000264	0.00169	CbGpPWpGaD
Aminosalicylic Acid—Headache—Timolol—glaucoma	0.000264	0.00112	CcSEcCtD
Aminosalicylic Acid—CHUK—Disease—LRP12—glaucoma	0.000251	0.00161	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Timolol—glaucoma	0.00025	0.00106	CcSEcCtD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NTRK1—glaucoma	0.000249	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TXNIP—glaucoma	0.000245	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000244	0.00156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.000243	0.00155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000242	0.00155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TBK1—glaucoma	0.00024	0.00154	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000239	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—TNF—glaucoma	0.000238	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000237	0.00152	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—CYP1B1—glaucoma	0.000236	0.00151	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ABCA1—glaucoma	0.000236	0.00151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NTRK2—glaucoma	0.000235	0.00151	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000235	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—CDKN1B—glaucoma	0.000234	0.0015	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CA1—glaucoma	0.000233	0.00149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000229	0.00146	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000227	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—BAD—glaucoma	0.000226	0.00145	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CTSA—glaucoma	0.000225	0.00144	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000225	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—BAD—glaucoma	0.000222	0.00142	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000219	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—C1QB—glaucoma	0.000217	0.00139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—BAD—glaucoma	0.000216	0.00139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000214	0.00137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—BAD—glaucoma	0.000213	0.00136	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CA2—glaucoma	0.000213	0.00136	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000211	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—CDKN1B—glaucoma	0.000211	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00021	0.00135	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000208	0.00133	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000208	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000207	0.00133	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NARFL—glaucoma	0.000207	0.00132	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CA5A—glaucoma	0.000207	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—CDKN1B—glaucoma	0.000206	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—CDKN1B—glaucoma	0.000204	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—BAD—glaucoma	0.000203	0.0013	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL1A—glaucoma	0.000203	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.000202	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—BAD—glaucoma	0.000202	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NGFR—glaucoma	0.000202	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—BAD—glaucoma	0.000201	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—BAD—glaucoma	0.0002	0.00128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—CDKN1B—glaucoma	0.000199	0.00128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—BAD—glaucoma	0.000198	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TXN—glaucoma	0.000193	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NTRK1—glaucoma	0.000192	0.00123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.00019	0.00122	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GSTM1—glaucoma	0.000189	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000189	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—BAD—glaucoma	0.000189	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—BAD—glaucoma	0.000189	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—GSTM1—glaucoma	0.000188	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—BAD—glaucoma	0.000187	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—BAD—glaucoma	0.000185	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—BAD—glaucoma	0.000184	0.00118	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	0.000181	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000179	0.00115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000179	0.00115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000177	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LRP12—glaucoma	0.000175	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—glaucoma	0.000175	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—BAD—glaucoma	0.000174	0.00112	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000174	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000171	0.0011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.00017	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—glaucoma	0.00017	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTSA—glaucoma	0.000169	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000167	0.00107	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—MTHFR—glaucoma	0.000167	0.00107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NARFL—glaucoma	0.000164	0.00105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA5A—glaucoma	0.000164	0.00105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000163	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR1OP—glaucoma	0.000161	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HEYL—glaucoma	0.000161	0.00103	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	0.000159	0.00102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—glaucoma	0.000158	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000157	0.00101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000157	0.001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NGF—glaucoma	0.000156	0.000998	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—APOE—glaucoma	0.000155	0.000996	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—CAV1—glaucoma	0.000154	0.000987	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	0.000152	0.000976	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000151	0.000965	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TXN—glaucoma	0.00015	0.00096	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—glaucoma	0.00015	0.00096	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LRP12—glaucoma	0.000148	0.000951	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—CDKN1B—glaucoma	0.000148	0.00095	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—MMP9—glaucoma	0.000146	0.000935	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000145	0.000932	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000144	0.000926	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000144	0.00092	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TXNIP—glaucoma	0.000143	0.000913	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—CDKN1B—glaucoma	0.000142	0.000907	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	0.000141	0.000905	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—CDKN1B—glaucoma	0.000141	0.000903	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—CDKN1B—glaucoma	0.00014	0.000899	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TBK1—glaucoma	0.00014	0.000896	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—CDKN1B—glaucoma	0.00014	0.000894	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000138	0.000881	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000137	0.000876	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000136	0.000868	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000131	0.000841	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000131	0.000841	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—CDKN1B—glaucoma	0.000131	0.000841	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00013	0.000836	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—CDKN1B—glaucoma	0.00013	0.000834	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000129	0.000826	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—BAD—glaucoma	0.000128	0.000823	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CDKN1B—glaucoma	0.000128	0.000823	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—C1QB—glaucoma	0.000126	0.00081	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000124	0.000794	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000124	0.000792	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000123	0.000787	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	0.000122	0.000783	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OPN4—glaucoma	0.000122	0.000779	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CDKN1B—glaucoma	0.000122	0.000778	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—NOS3—glaucoma	0.000116	0.000746	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000116	0.000745	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTT1—glaucoma	0.000116	0.000745	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000114	0.000727	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HEYL—glaucoma	0.000113	0.000724	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TXN—glaucoma	0.000113	0.000722	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTGFR—glaucoma	0.000109	0.000701	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	0.000108	0.000689	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTGS2—glaucoma	0.000107	0.000682	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000105	0.000673	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000103	0.000658	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CA1—glaucoma	0.000101	0.000646	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HDAC9—glaucoma	0.000101	0.000645	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MMP9—glaucoma	9.96e-05	0.000638	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CTSA—glaucoma	9.77e-05	0.000626	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	9.7e-05	0.000621	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HEYL—glaucoma	9.56e-05	0.000613	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR1OP—glaucoma	9.56e-05	0.000613	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.37e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—glaucoma	9.37e-05	0.0006	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ABCA1—glaucoma	9.26e-05	0.000593	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP1B1—glaucoma	9.26e-05	0.000593	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CA2—glaucoma	9.23e-05	0.000591	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.02e-05	0.000578	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.02e-05	0.000578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1B—glaucoma	8.94e-05	0.000573	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.81e-05	0.000564	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RPTOR—glaucoma	8.57e-05	0.000549	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—C3—glaucoma	8.44e-05	0.000541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCK2—glaucoma	8.3e-05	0.000532	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—C3—glaucoma	8.11e-05	0.000519	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2L1—glaucoma	8.08e-05	0.000518	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA1—glaucoma	8.01e-05	0.000513	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.76e-05	0.000497	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CTSA—glaucoma	7.76e-05	0.000497	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—glaucoma	7.67e-05	0.000491	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTM1—glaucoma	7.4e-05	0.000474	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BAD—glaucoma	7.33e-05	0.000469	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA2—glaucoma	7.32e-05	0.000469	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.32e-05	0.000469	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.16e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.16e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HDAC9—glaucoma	7.06e-05	0.000452	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—BAD—glaucoma	7.03e-05	0.000451	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—glaucoma	6.76e-05	0.000433	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—glaucoma	6.54e-05	0.000419	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TXN—glaucoma	6.5e-05	0.000416	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—glaucoma	6.09e-05	0.00039	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.09e-05	0.00039	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAV1—glaucoma	6.04e-05	0.000387	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HDAC9—glaucoma	5.97e-05	0.000382	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.93e-05	0.00038	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.88e-05	0.000377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1A—glaucoma	5.6e-05	0.000359	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SMO—glaucoma	5.52e-05	0.000354	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN2B—glaucoma	5.42e-05	0.000347	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.22e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TXN—glaucoma	5.16e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1B—glaucoma	5.1e-05	0.000327	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK2—glaucoma	5.05e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTT1—glaucoma	5.04e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—C3—glaucoma	4.92e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1B—glaucoma	4.9e-05	0.000314	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.71e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2L1—glaucoma	4.71e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.67e-05	0.000299	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.6e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—glaucoma	4.56e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—glaucoma	4.54e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGFR—glaucoma	4.33e-05	0.000278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BAD—glaucoma	4.27e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—glaucoma	4.23e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CAV1—glaucoma	4.19e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—glaucoma	4.17e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK1—glaucoma	4.12e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.06e-05	0.00026	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1B1—glaucoma	4.02e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCA1—glaucoma	4.02e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTT1—glaucoma	4e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BAD—glaucoma	3.94e-05	0.000252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—glaucoma	3.79e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDN1—glaucoma	3.64e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGF—glaucoma	3.34e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—glaucoma	3.21e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—glaucoma	3.21e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCA1—glaucoma	3.19e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1B1—glaucoma	3.19e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C3—glaucoma	3.18e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—glaucoma	3.17e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—glaucoma	2.97e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—glaucoma	2.96e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CAV1—glaucoma	2.93e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—glaucoma	2.9e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—glaucoma	2.84e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FN1—glaucoma	2.79e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BAD—glaucoma	2.76e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—glaucoma	2.74e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—glaucoma	2.69e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—glaucoma	2.64e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAV1—glaucoma	2.62e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—glaucoma	2.55e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—glaucoma	2.5e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CAV1—glaucoma	2.48e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BAD—glaucoma	2.33e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—glaucoma	2.25e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—glaucoma	2.22e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—glaucoma	2.1e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAV1—glaucoma	2.08e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—glaucoma	1.98e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—glaucoma	1.92e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—glaucoma	1.88e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—glaucoma	1.81e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—glaucoma	1.78e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—glaucoma	1.63e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—glaucoma	1.6e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—glaucoma	1.57e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—glaucoma	1.21e-05	7.73e-05	CbGpPWpGaD
